The Journey of Newborn Screening: Inception to Conclusion

  • ICMR Task Force on Inherited Metabolic Disorders



Writing Group: Dr. Seema Kapoor, Dr. Arun Singh. Steering Group: Late Dr. SS Aggarwal (Chairperson), Dr. I C Verma, Dr. Veena Kalra, Dr. Vasantha Muthuswamy and Dr. Vijay Kumar.

Compliance with Ethical Standards

Conflict of Interest


Source of Funding

Indian Council of Medical Research.


  1. 1.
    Ten great public health achievements. United States 2001–2010. Morb Mortal Wkly Rep. 2011;60:619–23.Google Scholar
  2. 2.
    Dutta R. ICMR to conduct first nation-wide newborn screening for genetic disorders. Express Healthcare Management [Internet]. 2005. Available at: Accessed on 7th June 2017.
  3. 3.
    Rama Devi AR, Naushad SM. Newborn screening in India. Indian J Pediatr. 2004;71:157–60.CrossRefPubMedGoogle Scholar
  4. 4.
    Gupta DK, Shilpa S, Amini AC, et al. Congenital adrenal hyperplasia: long-term evaluation of feminizing genitoplasty and psychosocial aspects. Pediatr Surg Int. 2006;22:905–9.CrossRefPubMedGoogle Scholar
  5. 5.
    ICMR Task Force on Inherited Metabolic Disorders. Newborn screening for congenital hypothyroidism and congenital adrenal hyperplasia: report of the ICMR National Task Force project. Indian J Pediatr. 2018.
  6. 6.
    Kapoor S, Thelma BK. Status of newborn screening and inborn errors of metabolism in India: a brief review. Indian J Pediatr. 2018. (in press).Google Scholar
  7. 7.
    ICMR Task Force on Inherited Metabolic Disorders. High Risk stratified screening. Indian J Pediatr. 2017.
  8. 8.
    ICMR Task Force on Inherited Metabolic Disorders. Normative data for thyroid stimulating hormone for screening of congenital hypothyroidism. Indian J Pediatr 2017.

Copyright information

© Dr. K C Chaudhuri Foundation 2018

Authors and Affiliations

  • ICMR Task Force on Inherited Metabolic Disorders
    • 1
  1. 1.Division of Molecular and Clinical MedicineDundeeUK

Personalised recommendations